XML 54 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Basis of Presentation (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 01, 2019
USD ($)
Mar. 01, 2019
USD ($)
Jul. 31, 2019
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Aug. 01, 2019
KRW (₩)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Net loss       $ 23,090,693 $ 25,015,672 $ 81,697,181 $ 64,005,625    
Working capital       79,300,000   79,300,000      
Retained earnings (accumulated deficit)       (702,123,617)   (702,123,617)   $ (620,426,436)  
Cash, cash equivalents, and short-term investments       93,800,000   93,800,000      
Long-term investments       8,000,000   8,000,000      
Proceeds from issuance of stock           $ 3,425,065 $ 14,923,263    
Expected number of positions to be eliminated, percent     28.00%            
Restructuring charges       $ 2,200,000          
Geneos Therapeutics, Inc.                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Non-controlling interest       39.00%   39.00%      
VGX Animal Health, Inc                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Non-controlling interest       15.00%   15.00%      
Common stock | Sales Agreement                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Stock sales agreement, remaining authorized sales amount       $ 68,500,000   $ 68,500,000      
Proceeds from issuance of stock       1,100,000   3,400,000   $ 29,200,000  
6.50% Convertible Senior Notes Due 2024 | Convertible Debt                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Proceeds from issuance of debt   $ 75,700,000       75,700,000      
Principal amount   $ 78,500,000.0   $ 78,500,000   $ 78,500,000      
Debt instrument, interest rate, stated percentage   6.50%   6.50%   6.50%      
Korean Won Convertible Bonds Due 2024 | Convertible Debt                  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                  
Proceeds from issuance of debt $ 14,500,000                
Principal amount $ 15,000,000     $ 15,052,055   $ 15,052,055     ₩ 18,000,000,000
Debt instrument, interest rate, stated percentage 1.00%               1.00%